A group of scientists has written to the European Commission to voice concerns about burden of proof and confused evidence requirements to identify and classify endocrine disruptors under the PPP and Biocides Regulations.
The precautionary principle may be scrapped in the EU's free trade agreements with Canada and the United States. According to the NGO Foodwatch, this could call into question the bloc's bans on hormone-treated beef and GMOs. EurActiv France reports.
MEPs have castigated the European Commission over the delay to the definition of endocrine disruptors and demanded swift action. Initially due for December 2013, the definition has fallen two and a half years behind schedule. EurActiv France reports.
The debate on hormone disruptors in the EU is more political than scientific. A decision to ignore the question of potency would cause needless disruption to regulators, industries and consumers, writes Christopher Borgert.
More and more women are finding it difficult to get pregnant, with mounting evidence suggesting chemicals used in plasticisers and pesticides are responsible. The consequences are estimated to cost the EU €1.4 billion per year. EurActiv Germany reports.
Endocrine disruptors pose a substantial risk to public health, yet the European Commission has dawdled time and again on introducing measures that would finally limit their use. Now is the time to put this right, write Genon Jensen and Michael Warhurst.
The European Commission’s drive to simplify legislation for businesses – the Better Regulation Agenda – has come under fire from trade unions for blocking EU laws that could save thousands of lives per year.